Eyecelerator @ AAO 2022
Thursday, September 29
McCormick Place, Chicago

McCormick Place Convention Center, E354

​

Program Chair Gil Kliman, MD

Program Co-Chairs Allen C. Ho, MD and Julie Schallhorn, MD 

​

Moderator: Stephen D. McLeod, MD
CEO, American Academy of Ophthalmology

How Will the 2022 Midterm Elections Impact Healthcare?

• Jeffrey Kimbell, President & CEO, Kimbell & Associates 
  Political insider Jeff Kimbell prognosticates on the outcomes of the 2022 and 2024 US elections and the potential impact on the life sciences community.

Ophthalmology Year in Review

• Kristen Harmon Ingenito, Director of Ophthalmics, Market Scope  
  Start the day with a data-driven and sometimes surprising look at the business of Ophthalmology.

​

Panel:

• Wiley A. Chambers, MD, Food & Drug Administration

• Malvina B. Eydelman, MD, Food & Drug Administration

• Andrew Gitkin, Raymond James

• Peter Menziuso, Company Group Chairman, Johnson & Johnson Vision

• Euan S. Thomson, PhD, President, Ophthalmic Devices and Head of Digital Business, Carl Zeiss Meditec
   

Moderator: Gil Kliman, MD

A diverse, multigenerational panel of investment experts explore the interdependent roles of venture capital, private financing and global strategics in funding the next wave of eye care innovation.

Panel: 

• Franck Leveiller, Alcon

• William Link, PhD, Flying-L-Partners

• Mariam Maghribi, PhD, MBA, Shifamed

• Biren Mehta, Venture Investments, Johnson & Johnson 

• Jeffry Weinhuff, Visionary Ventures
   

Enjoy refreshments and connect with your colleagues.
 

A  timely assessment of the real-world data driving a new generation of treatments and medical vs. surgical solutions for patients.

Moderators: Zaina Al-Mohtaseb, MD and Julie Schallhorn, MD
 

Panel:

• Jeannette Bankes, Alcon

• Sumit Garg, MD, LensGen

• Yari L. Mitchell, AcuFocus, Inc.

• Erin Powers, BVI Medical 

• Neda Shamie, MD, Visus Therapeutics  

• Ramin Valian, Allergan, an AbbVie Company
   

Seven innovative retina and AI companies will showcase the newest treatments and technologies, while panel experts analyze the clinical and market opportunities.

Moderators: Robert L. Avery, MD and Allen C. Ho, MD

​

Panel:

• Megan Baldwin, PhD, Opthea 

• Durga Borkar, MD, Verana 

• Wiley A. Chambers, MD, Food & Drug Administration

• Pravin Dugel, MD, IvericBio

• Cedric Francois, MD, PhD, Apellis 

• Kester Nahen, PhD, Notal Vision, Inc. 

• Stephen Pakola, MD, RegenXBio

​​

​Presentations: 

• Apellis, Cedric Francois, MD, PhD, Co-Founder and CEO 
   

• IvericBio Dhaval B. Desai, SVP & Chief Development Officer
   

• Gyroscope, a Novartis Company, J. Jill Hopkins, MD, FRSCS, SVP, Global Head Ophthalmology Development Unit 
   

• RegenXBio, Stephen Pakola, MD, Chief Medical Officer 
   

• Opthea, Megan Baldwin, PhD, CEO and Managing Director
   

• Verana, Durga Borkar, MD, Medical Advisor
   

• Notal Vision, Inc., Kester Nahen, PhD, CEO

​

Government, academic, and industry experts offer perspectives on benchmarking practices that accurately characterize the effectiveness of treatments in clinical studies and meet regulatory requirements.
 

Moderators: Mark S. Humayun, MD, PhD and Arsham Sheybani, MD

​

Panel:

• Mark S. Blumenkranz, MD, MMS, Byers Eye Institute at Stanford University 

• Wiley A. Chambers, MD, Food & Drug Administration

• Terry Dagnon, Outlook Therapeutics

• Malvina B. Eydelman, MD, Food & Drug Administration

• Peter K. Kaiser, MD, Cleveland Clinic Lerner College of Medicine

• Omar Sadaruddin, MD, Santen

• Matt Schlenker, MS, MD, University of Toronto 
   

Buffet served.
 

The 'Shark Tank' -styled competition returns to the Eyecelerator stage. Three early-stage companies will compete for free access to experienced mentors, networking opportunities, exposure to financial resources, and up to $45,000 in prize money. 

​

Moderators: John P. Berdahl, MD and Vance M. Thompson, MD

Pitch Finalists
 

• Vincente Diaz, MD, MBA, Sustained Drug Delivery
  ​

• Alejandro Navas, MD, PhD, FACS, New Sight Pharma
   

• Sunil Patel MD, PhD, Allgenesis Biotherapeutics

Panel Judges: ​

• Vartan Ghazarossian, PhD, CEO, Stepwise Medical 

• Ranya G. Habash, MD, CEO, Lifelong Vision   

• Richard L. Lindstrom, MD, Founder, Minnesota Eye Consultants

• William J. Link, PhD, Managing Partner, Flying-L Partners

​​

​

A diverse line up of 40+ companies, more than half appearing at Eyecelerator for the first time, will present novel treatments and technologies at all stages of production in a unique, interactive format. Audience members are invited to ask questions. 

Breakout rooms will operate simultaneously for each segment. Follow these links for showcase schedules:

RETINA SHOWCASE

THERAPEUTICS SHOWCASE: IMPLANTS AND PHARMACEUTICALS

TECHNOLOGY AND DEVICES SHOWCASE

​

Find refreshments and connect with your colleagues.
 

Moderator Preeya K. Gupta, MD, engages a panel of inspired leaders who are bringing the future of ophthalmology into focus. Each offers a distinct perspective on the industry and the requirements for bringing innovation into the marketplace.

Moderator: Preeya K. Gupta, MD

Panelists:

• Andrew Chang, Global Head of Sales, Ophthalmic Devices, Carl Zeiss Meditec 

• Ranna Jaraha, Executive Director New Media, BMC 

• Bindu Manne, Head, Market Development and Commercialization, Ocuphire 

• Maaza Martin, MS, Senior Director, Marketing, Tarsus Pharmaceuticals

​

Moderators: Allen C. Ho, MD and Julie Schallhorn, MD 
 

Best of Show awards presented